Skip to content
2000
Volume 11, Issue 3
  • ISSN: 1573-3998
  • E-ISSN: 1875-6417

Abstract

The identification of at-risk individuals prior to transplantation may enable implementation of measures to prevent or delay PTDM development, while early detection facilitates prompt management and may prevent acute and chronic complications. Thus, in this review, we examine proposed tools for the prediction of PTDM for use prior to and following solid organ transplantation. This includes PTDM prediction models based on biochemical assessments of glycaemia and other indices, in addition to those solely based on clinical parameters. We also examine the available methods for diagnosis of PTDM early and late post-transplant, including the advantages and limitations of fasting plasma glucose (FPG), OGTT, random plasma glucose and HbA1c assessment. Key findings are that OGTT should remain the gold standard diagnostic method for PTDM, however, there is emerging data to support a role for HbA1c beyond 3 months posttransplant. FPG has low sensitivity during the first year post-transplant. Improved prediction and diagnosis of PTDM may lead to improvements in patient survival, quality of life and health care costs in future.

Loading

Article metrics loading...

/content/journals/cdr/10.2174/1573399811999150316105553
2015-09-01
2025-06-12
Loading full text...

Full text loading...

/content/journals/cdr/10.2174/1573399811999150316105553
Loading

  • Article Type:
    Research Article
Keyword(s): diagnosis; Post transplant diabetes; prediction; PTDM
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test